Publication: 4727

Publication: 4727

WGS- and WES-informed circulating tumor DNA analysis to assess minimal residual disease for prediction of benefit from palbociclib and prognosis in the PALLAS trial (AFT-05)

Google Scholar

Citation:

Meeting Instance:: SABCS 2025
Year:: 2025
Type:: Abstract
Sub type:
Funding:: AFT
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Pfizer;
Grants:: AFT, ABCSG, ECOG-ACRIN, NSABP Foundation, GBG, BIG;

Corr. Author:
Authors:: Heather Parsons Karla Ballman Ellen Heitzer Mark Watson Marija Balic Dominik Hlauschek Guenther G. Steger Justin M. Balko Yelena Novik Miguel Martin Zoneddy R Dayao Arlene Chan Einav Nili Gal-Yam Claudine Isaacs Maarte Los Juan Miguel Gil Gil Baerbel Felder Carsten Denkert Peter Fasching Feng Liu Taylor O'Donnel Erica L Mayer Michael Gnant William Fraser Symmans Angela DeMichele

Networks:: CAPITAL, LAPS-MA036, LAPS-MO011, LAPS-PA015, LAPS-TX035, NEWMEXICO

Study: AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: